PDL BioPharma to Present at Oppenheimer & Co. 20th Annual Healthcare Conference on November 4, 2009
- Press Release
- Source: PDL BioPharma, Inc.
- On 5:15 pm EDT, Tuesday October 27, 2009
INCLINE VILLAGE, Nev., Oct. 27 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI - News) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the Oppenheimer 20th Annual Healthcare Conference in New York City on Wednesday, November 4, 2009 at 9:40 a.m. Eastern Time
Related Quotes
| Symbol | Price | Change |
|---|---|---|
| PDLI | 7.86 | -0.04 |
To access the live and subsequently archived webcast of the conference call, go to the company's website at http://www.pdl.com and click "Investors." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. A replay will be available at www.pdl.com starting approximately three hours after completion of the webcast.
About PDL BioPharma, Inc.
PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The company receives royalties on sales of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody products launched before patent expiry in late 2014. For more information, please visit www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
Related Headlines
- PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend - PR Newswire
- PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits - EDGAR Online
- Five Dividend Stocks With Growth Potential - at Investopedia
- PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits - EDGAR Online
- PDL BioPharma declares special dividend - AP
Related Blog Headlines
- Klarman, Whitman Are Sellers But Witmer Buys in Q3 2009 - at Seeking Alpha
- Baupost Initiates Enzon Position, Ups ViaSat Stake - at Seeking Alpha
- Two Stocks with Market Caps Over $250 Million That Sell for Under $10 - at Seeking Alpha
Sponsored Links
-
Try Forex Currency Trading at Forex.com
Free $50,000 practice account with real-time charts news and research. -
Compare Top CD Rates
Search CDs from 100s of Banks Plus News, Tips, Advice and More.
-
Become A Law Enforcement Officer
SWAT, K9, Narcotics, CSI & More. Online Degrees For Police Careers. -
Trade Stocks? Try Currency Trading
Trade in a highly trending market 24-hrs a day, 5.5 days a week. GFT.
Tech Ticker Recent Posts
Add Alert Copyright © 2009 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.